TC BioPharm (Holdings) plc Quarterly Deferred Tax Assets, Gross in GBP from Q4 2022 to Q4 2023

Taxonomy & unit
us-gaap: GBP
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
TC BioPharm (Holdings) plc quarterly Deferred Tax Assets, Gross history and growth rate from Q4 2022 to Q4 2023.
  • TC BioPharm (Holdings) plc Deferred Tax Assets, Gross for the quarter ending December 31, 2023 was £4.45M, a 7.44% decline year-over-year.
Deferred Tax Assets, Gross, Quarterly (GBP)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 4.45M -358K -7.44% Dec 31, 2023 10-K 2024-04-01
Q4 2022 4.81M Dec 31, 2022 10-K 2024-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.